» Articles » PMID: 34681250

Modular Synthesis and Antiproliferative Activity of New Dihydro-1-pyrazolo[1,3-]pyridine Embelin Derivatives

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Oct 23
PMID 34681250
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A set of new dihydro-1-pyrazolo[1,3-]pyridine and pyrazolo[1,3-]pyridine embelin derivatives was synthesized through a multicomponent reaction from natural embelin, 3-substituted-5-aminopyrazoles and aldehydes. The synthesized compounds were evaluated against three hematologic tumor cell lines, HEL (acute erythroid leukemia), K-562 (chronic myeloid leukemia) and HL-60 (acute myeloid leukemia), and five breast cancer cell lines (SKBR3, MCF-7, MDA-MB-231, BT-549, HS-578T). The primate non-malignant kidney Vero cell line was used as the control of cytotoxicity. From the obtained results, some structure-activity relationships were outlined. Furthermore, in silico prediction of physicochemical properties and ADME parameters were determined for the derivatives with the best antiproliferative values.

Citing Articles

Antiproliferative activity of antimicrobial peptides and bioactive compounds from the mangrove .

Karthik Y, Kalyani M, Krishnappa S, Devappa R, Anjali Goud C, Ramakrishna K Front Microbiol. 2023; 14:1096826.

PMID: 36876075 PMC: 9982118. DOI: 10.3389/fmicb.2023.1096826.


Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents.

Martin-Acosta P, Cuadrado I, Gonzalez-Cofrade L, Pestano R, Hortelano S, de Las Heras B J Nat Prod. 2023; 86(2):317-329.

PMID: 36749898 PMC: 9972480. DOI: 10.1021/acs.jnatprod.2c00924.


Embelin and Its Derivatives: Design, Synthesis, and Potential Delivery Systems for Cancer Therapy.

Danquah M Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145352 PMC: 9505931. DOI: 10.3390/ph15091131.


Green Synthesis and Anticancer Potential of 1,4-Dihydropyridines-Based Triazole Derivatives: In Silico and In Vitro Study.

Bijani S, Iqbal D, Mirza S, Jain V, Jahan S, Alsaweed M Life (Basel). 2022; 12(4).

PMID: 35455010 PMC: 9029820. DOI: 10.3390/life12040519.

References
1.
Zhao B, Li Y, Xu P, Dai Y, Luo C, Sun Y . Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors. ACS Med Chem Lett. 2016; 7(6):629-34. PMC: 4904267. DOI: 10.1021/acsmedchemlett.6b00066. View

2.
Gillis E, Eastman K, Hill M, Donnelly D, Meanwell N . Applications of Fluorine in Medicinal Chemistry. J Med Chem. 2015; 58(21):8315-59. DOI: 10.1021/acs.jmedchem.5b00258. View

3.
Chebanov V, Saraev V, Desenko S, Chernenko V, Knyazeva I, Groth U . Tuning of chemo- and regioselectivities in multicomponent condensations of 5-aminopyrazoles, dimedone, and aldehydes. J Org Chem. 2008; 73(13):5110-8. DOI: 10.1021/jo800825c. View

4.
Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View

5.
Kombarov R, Altieri A, Genis D, Kirpichenok M, Kochubey V, Rakitina N . BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery. Mol Divers. 2009; 14(1):193-200. DOI: 10.1007/s11030-009-9157-5. View